Boyd Biomedical, Inc.

© 2026 Boyd Biomedical, Inc.

DISCIPLINES

Evidence & Insights

Clinicians, payers, and buyers adopt what the evidence supports. We help you ground commercial decisions in what these stakeholders need to see, and build the scientific credibility that drives adoption.

×

Please feel out the form below and someone from our team will contact you shortly.
disciplines_LBB_evidence-insights_color_800x800

Overview

Evidence and insights connect your clinical program to your commercial strategy. We help biomedical innovators understand stakeholder needs through primary research, build relationships with key opinion leaders, and plan the clinical and real-world evidence that supports reimbursement and adoption. The result is an evidence base designed to meet the expectations of the stakeholders who decide your device’s success.

What evidence and insights covers

Evidence and insights turn clinical data into commercial conviction. Our work helps you understand what stakeholders need, engage the clinical voices they trust, and generate the evidence that supports your case.

  • Market Research

    Primary research with clinicians, payers, and buyers that informs strategy with real-world insight.

  • Medical Affairs

    Key opinion leader engagement, advisory boards, and publication planning that build scientific credibility.

  • Evidence Planning

    Evidence planning across clinical studies and real-world data to support adoption and reimbursement.

Where evidence and insights shows up

Evidence and insights should lead once clinical work begins, so that studies generate the data clinicians, payers, and buyers will require. The work continues after launch through real-world evidence and ongoing KOL engagement.

PHASE 0

Foundation

Supports market assessment with primary stakeholder research.

PHASE 1

Clinical Evidence

Leads evidence strategy, KOL engagement, and clinical stakeholder research.

PHASE 2

Pivotal Development

Leads KOL relationships and publication planning ahead of data readout.

PHASE 3

Regulatory Submission

Supports early stakeholder engagement while the submission is under review.

PHASE 4

Market Clearance

Supports clinical messaging and KOL advocacy ahead of market entry.

PHASE 5

Commercial Launch

Supports publication and KOL programs that reinforce launch messaging.

PHASE 6

Growth

Leads real-world evidence and ongoing KOL engagement.

The ROI on better evidence and insights

Evidence that doesn’t answer stakeholder questions delays adoption and reimbursement. Planning evidence around clinician, payer, and buyer requirements helps your clinical investment deliver commercial value.

Better-Informed Decisions

Commercial strategy grounded in direct stakeholder insight.

Clinical Credibility

KOL support and publications that build trust with clinical audiences.

Reimbursement-Ready Evidence

Data designed to meet payer and health system requirements.

Faster Adoption

Evidence that answers clinician questions before they slow adoption.

Explore our disciplines

Every program draws on a different combination of our core disciplines to build the path from innovation to adoption.

  • disciplines_LBB_go-to-market_mono_800x800

    Go-to-Market

    Turn strategy into launch plans and marketing programs that drive adoption.

  • disciplines_LBB_commercial-strategy_mono_800x800

    Commercial Strategy

    Choose the right market, define a differentiated position, and confirm the opportunity justifies the investment

  • disciplines_LBB_market-access_mono_800x800

    Market Access

    Build the path to payment and purchase, from coding and coverage to contracts.

  • disciplines_LBB_evidence-insights_mono_800x800

    Evidence & Insights

    Ground commercial decisions in what clinicians, payers, and buyers need to see.

Content Card - Just Mighty - Launch - Two Color - Full (1920 x 1080)
Logo - Just Mighty - White Logo (400 x 400)

Your innovation Just Might change the world. But is your strategy up to the task? We help you turn Just Might into Just Mighty.